心房颤动抗凝治疗误区

[1] Evidence-Based Management of Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J] . Anne Holbrook,Sam Schulman,Daniel M. Witt,Per Olav Vandvik,Jason Fish,Michael J. Kovacs,Peter J. Svensson,David L. Veenstra,Mark Crowther,Gordon H. Guyatt.Chest . 2012 (2)

[2] Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion[J] . Rangadham Nagarakanti,Michael D. Ezekowitz,Jonas Oldgren,Sean Yang,Michael Chernick,Timothy H. Aikens,Greg Flaker,Josep Brugada,Gabriel Kamensky,Amit Parekh,Paul A. Reilly,Salim Yusuf,Stuart J. Connolly.Circulation . 2011 (2)

[3] Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial[J] . Jonathan Mant,FD Richard Hobbs,Kate Fletcher,Andrea Roalfe,David Fitzmaurice,Gregory YH Lip,Ellen Murray.The Lancet . 2007 (9586)

[4] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial[J] . The Lancet . 2006 (9526)

[5] Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study[J] . John P. DiMarco,Gregory Flaker,Albert L. Waldo,Scott D. Corley,H. Leon Greene,Robert E. Safford,Lynda E. Rosenfeld,Gladys Mitrani,Margit Nemeth.American Heart Journal . 2005 (4)

[6] Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10[J] . Karen E Gunther,Gladys Conway,Linda Leibach,Mark A Crowther.Thrombosis Research . 2004 (3)

[7] Timing of thromboembolic events after electical cardioversion of atrial fibrillation or flutter: a retrospective analysis[J] . Marvin Berger,Paul Schweitzer.The American Journal of Cardiology . 1998 (12)

[8] Atrial Fibrillation as an Independent Risk Factor for Stroke: The Framingham Study[J] . Philip A. Wolf,Robert D. Abbott,William B. Kannel.Stroke . 1991 (8)

[9] Warfarin dose assessment every4weeks versus every 12 weeks in patients with stable international normalized ratios:a randomized trial .2 Schulman S,Parpia S,Stewart C,Rudd-Scott L,Julian J,Levine M. Ann Intern Med . 2011

[1] Evidence-Based Management of Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J] . Anne Holbrook,Sam Schulman,Daniel M. Witt,Per Olav Vandvik,Jason Fish,Michael J. Kovacs,Peter J. Svensson,David L. Veenstra,Mark Crowther,Gordon H. Guyatt.Chest . 2012 (2)

[2] Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion[J] . Rangadham Nagarakanti,Michael D. Ezekowitz,Jonas Oldgren,Sean Yang,Michael Chernick,Timothy H. Aikens,Greg Flaker,Josep Brugada,Gabriel Kamensky,Amit Parekh,Paul A. Reilly,Salim Yusuf,Stuart J. Connolly.Circulation . 2011 (2)

[3] Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial[J] . Jonathan Mant,FD Richard Hobbs,Kate Fletcher,Andrea Roalfe,David Fitzmaurice,Gregory YH Lip,Ellen Murray.The Lancet . 2007 (9586)

[4] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial[J] . The Lancet . 2006 (9526)

[5] Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study[J] . John P. DiMarco,Gregory Flaker,Albert L. Waldo,Scott D. Corley,H. Leon Greene,Robert E. Safford,Lynda E. Rosenfeld,Gladys Mitrani,Margit Nemeth.American Heart Journal . 2005 (4)

[6] Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10[J] . Karen E Gunther,Gladys Conway,Linda Leibach,Mark A Crowther.Thrombosis Research . 2004 (3)

[7] Timing of thromboembolic events after electical cardioversion of atrial fibrillation or flutter: a retrospective analysis[J] . Marvin Berger,Paul Schweitzer.The American Journal of Cardiology . 1998 (12)

[8] Atrial Fibrillation as an Independent Risk Factor for Stroke: The Framingham Study[J] . Philip A. Wolf,Robert D. Abbott,William B. Kannel.Stroke . 1991 (8)

[9] Warfarin dose assessment every4weeks versus every 12 weeks in patients with stable international normalized ratios:a randomized trial .2 Schulman S,Parpia S,Stewart C,Rudd-Scott L,Julian J,Levine M. Ann Intern Med . 2011